Role of miR-223 in the pathophysiology of liver diseases
- PMID: 30258086
- PMCID: PMC6158210
- DOI: 10.1038/s12276-018-0153-7
Role of miR-223 in the pathophysiology of liver diseases
Abstract
MiRNAs are small, noncoding RNAs, which can regulate gene expression posttranscriptionally, and they have emerged as key factors in disease biology by aiding in disease development and progression. MiR-223 is highly conserved during evolution and it was first described as a modulator of hematopoietic lineage differentiation. MiR-223 has an essential part in inflammation by targeting the nuclear factor-κB pathway and the nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome. Recent studies have shown that miR-223 expression is deregulated in various types of liver diseases, including hepatitis virus infections, alcohol-induced liver injury, drug-induced liver injury, non-alcoholic fatty liver disease, cirrhosis, and hepatocellular carcinoma. As inflammatory and immune factors are involved in the occurrence and progress of liver diseases, deregulated miR-223 may participate in the pathogenesis of these conditions by influencing neutrophil infiltration, macrophage polarization, and inflammasome activation. This review first summarizes the present understanding of the biological functions of miR-223, including its gene location and transcription regulation, as well as its physiological role in hematopoietic differentiation. This review then focuses on the role of miR-223 in liver pathophysiology and its potential applications as a diagnostic biomarker and therapeutic target in liver diseases.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures

Similar articles
-
Regulation of the MIR155 host gene in physiological and pathological processes.Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Gene. 2013. PMID: 23246696 Review.
-
MicroRNAs in liver disease.Gastroenterology. 2012 Jun;142(7):1431-43. doi: 10.1053/j.gastro.2012.04.007. Epub 2012 Apr 11. Gastroenterology. 2012. PMID: 22504185 Free PMC article. Review.
-
The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity.Int J Mol Sci. 2018 Jan 16;19(1):261. doi: 10.3390/ijms19010261. Int J Mol Sci. 2018. PMID: 29337905 Free PMC article. Review.
-
miR-122--a key factor and therapeutic target in liver disease.J Hepatol. 2015 Feb;62(2):448-57. doi: 10.1016/j.jhep.2014.10.004. Epub 2014 Oct 13. J Hepatol. 2015. PMID: 25308172 Review.
-
MiR-122 in hepatic function and liver diseases.Protein Cell. 2012 May;3(5):364-71. doi: 10.1007/s13238-012-2036-3. Epub 2012 May 18. Protein Cell. 2012. PMID: 22610888 Free PMC article. Review.
Cited by
-
MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease.Int J Biol Sci. 2021 Apr 29;17(7):1851-1863. doi: 10.7150/ijbs.59588. eCollection 2021. Int J Biol Sci. 2021. PMID: 33994867 Free PMC article. Review.
-
The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC.Int J Mol Sci. 2022 Oct 15;23(20):12370. doi: 10.3390/ijms232012370. Int J Mol Sci. 2022. PMID: 36293225 Free PMC article. Review.
-
Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential.Front Immunol. 2022 Oct 10;13:985815. doi: 10.3389/fimmu.2022.985815. eCollection 2022. Front Immunol. 2022. PMID: 36300115 Free PMC article. Review.
-
An Overview of Inter-Tissue and Inter-Kingdom Communication Mediated by Extracellular Vesicles in the Regulation of Mammalian Metabolism.Int J Mol Sci. 2023 Jan 20;24(3):2071. doi: 10.3390/ijms24032071. Int J Mol Sci. 2023. PMID: 36768391 Free PMC article. Review.
-
The role of autophagy in hepatic fibrosis.Am J Transl Res. 2021 Jun 15;13(6):5747-5757. eCollection 2021. Am J Transl Res. 2021. PMID: 34306323 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials